Member Info for neilrich3

Hi Larry, I don't have names unfortunately, I'm going by the summary upon Linkedin for where the employees lives, this past week employees within France increased to three. Might mean something, but could be nothing.

It would appear that the Novacyt headcount is increasing within France, based upon Linkedin, there's been a 50% increase from 2 to 3 employees.

Poidster, The RNS clearly states 'CO-PrepTM has been designed to automate the liquid handling steps of the Company’s near-patient PROmate® test,' however I do hope you're correct.

It would appear so, in other news Novacyt have appointed a Digital Brand Manager.

Checking Graham's Linkedin, it would appear that he has not retired, but looking for new opportunities!!
Retired CEO looking to help companies.

A healthcare experienced CEO who has the skills to develop and commercialise new technologies, build high growth, successful businesses and create shareholder value. Extensive international experience including living and working in the US, Ireland and Singapore. Includes significant M&A experience from targeted roll-up strategies. Building high performing teams is both rewarding and fun.

Specialties: Significant international CEO experience in Pharma, Biotech, Medical Device and Diagnostic sectors.

Hopefully we shall have a better idea when they reveal the provisional Q3, possibly next week.

For all we know the DHSC dispute could have been settled, Nick's job is done, however perhaps the company is prevented from making an announcement at present under the settlement agreement. Clutching at straws!

Nick Plummer has been removed from the Executive Management Team upon the Novacyt website, although Linkedin suggesting that he is still employed by Novacyt.

Monkeyfish, Please can you expand upon the line below, unfortunately I was unable to follow the AGM/EGM.

Along with GM’s previous comment on the investor presentation that the NHS/DHSC were using Qs under the disputed contract for the Promate under new NHS framework contract, it’s starting to come together…

More than likely our Winterplex branded under Molbiol....

Complete OEM solutions

We can project manage the entire OEM process for your organisation. This entails complete, seamless integration of your branding in to our operations workflow to ensure your products are packaged and specified in the format you prefer.

White label or full branded solutions

We can supply goods in bulk under white label for your own repackaging systems. Alternatively we can create new packaging solutions to your specification complete with your own branding. Or if you prefer we can pack directly in to your own packaging solution. Product handbooks and protocols can be rebranded alongside packaging too.

After all.....we are only two weeks into Q4!

They've already stated on three occasions, 2021 revenue expected to be £100m excluding DHSC, most recently reaffirmed by the company at the end of September. I'm sure that they shall update us with exact figures for Q3 when they are ready and not before, too many people here trying to put two and two together and getting seven.

Yeah, but PROmate is not being used within the Megalabs, some on this board were calling for a PROmate Winterplex™ however clearly there's a reason why the company haven taken an alternative route, my guess would be that the customer has specifically requested Winterplex™ for use in central laboratories.

EscapePLEX™ and Winterplex™ both designed for use in central laboratories, I'd imagine this definition includes the UK Mega Labs.

Six months with their head beneath the the parapet, working closely with their largest customer to deliver a product specified by the DHSC, both working together to ensure resolution of the dispute.

I'd have thought that Leamington Spa being a purpose built Mega Lab shall be processing a lot more than 20k tests a day, I'd guess that the number shall be around the 100k mark minimum.

Also, Q32....what are you suggesting? There shall be no Q32 in use at the Mega labs.

https://www.gov.uk/government/news/rosalind-franklin-laboratory-processes-one-millionth-pcr-test

My money is on this being EscapePLEX™, have already established a NCYT link to the Leamington Spa facility. Also, I think that EscapePLEX™ and Winterplex have both been developed specifically for the DHSC, both have been working together to ensure that Novacyt deliver these new products, which in turn resolves the dispute, hence the radio silence for six months, imagine a new mega contract, a Win Win for both sides? This passed weeks the company tweets elude an air of confidence, only yesterday Novacyt Group publicly engaged with a share holder upon Twitter, perhaps GM really does have something up his sleeve before departure.

In the coming weeks the laboratory will begin genotype assay testing to rapidly detect known COVID-19 mutations and genome sequencing to confirm known variants and identify any new mutations.The megalab is the biggest of its kind in the UK and has created employment for local people, with 600 new staff already. Around 60% of staff hired so far are from within 30 miles of the laboratory site in Leamington Spa.

I believe that the only thing stoping USA sales is the fact that many of our products currently marketed within the USA are research use only (RUO). Also, once our key products gain FDA approval, this shall be the point at which Novacyt Inc. established as sales force, would be pointless at present, pushing products for RUO.

Hopefully FDA approval is close.

https://katalysthealth.uk/fit-to-fly/fit-to-fly-heathrow-airport/

https://research-centre.barclays.co.uk

The consensus is taken from the Barclays Research Centre, the research indicates two brokers. Anybody can use the Research Centre, not just Barclays customers.